Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Bullboard Posts
Post by TallerCraigon Aug 28, 2018 8:31am
403 Views
Post# 28527976

Q3: Crushed it: 60.3% EBITDA Growth w Bad Debt Down to 6%...

Q3: Crushed it: 60.3% EBITDA Growth w Bad Debt Down to 6%...What a Quarter, clearly I was too conservative! From the top to the bottom line looks good, Just going to start off by saying how far the Beacon Analyst is now behind the story with his 0.40/share Price Target with only a 12.1M FY’19 EBITDA target. (I am at 18.5M EBITDA now). Numbers and Price Target needs to go higher. Lets Dig in;
 
Revenue
 
19.72M in revenue up 5% YoY but under the hood looks even better. Organic Patients served up 6% and coupled with continued 20% growth in higher margin Respiratory Resupply Setups is critical to future growth.
 
Organic growth with a Currency kicker looking out 12 months I like it! Could set up a period of double digit revenue growth in FY 19 even before you consider acquisitions.
 
 
Profitability
 
3.6M in EBITDA up 60.3% QoQ trumps the profitability growth that VMD.TO is putting up, already hitting their 18% EBITDA margin target the exact Q after putting the target out there and ahead of schedule, management is dialing in the business quicker then they even projected. 
 
Lets just take a minute and appreciate the operating efficiency this company has been able to put up post VMD spin. EBITDA margins by Quarter (Q3: 18.3% Q2: 11.9% Q1: 8.1%). 120% expansion in EBITDA margins in only 3Qs!!! Are you serious. Scary thing is I think there could be another 500+ basis points in margin expansion in the next 12 months.
 
 
Of course have to look at Bad Debt. Looks great, Bad Debt down to 6% of Sales down QoQ and YoY. A/R collections has been a key leg to the recovery.
 
 
Looking Ahead
 
We will have to see how the call goes but this story is just getting going. The street has to take serious now managements guide to mid to low 20% EBITDA margin in FY19 which is a game changer.
 
Using a 22% margin on a 85M Revenue top line gets me to an EBITDA estimate of 18.5M.  You put a 8-10x EBITDA multiple on that and you get a price range of 0.35 – 0.44/share or 0.395/share at the mid point or 200% upside with a multiple re rating.
 
Congratulations Greg and Team, great Q. Organically the business is doing great and talk on acquisitions is just gravy.
 
 
LONG

Bullboard Posts